DSCAM and breast cancer: Niknafs et al.22 and Minao et al.23 discovered that DSCAM-AS1 was under transcriptional regulation by ERα, and over-expression of DSCAM-AS promotes proliferation, invasion and tamoxifen resistance in breast cancer 22.